FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, in particular to pharmaceutical composition for treatment of oncologic diseases in form of phospholipid nanoparticles with size 10-30 nm, which includes phosphatidelcholin, maltose and doxorubicine with the following ratio of components, wt. %: phosphatidelcholin 20-43, maltose 55-78, doxorubicine 2-8. Composition is accumulates in tumour tissue more actively and slows down tumour growth in mice with carcinoma LLC more efficiently in comparison with free doxorubicine.
EFFECT: composition represents freeze-dries powder, stable in long storage, which dissolving in water gives nanophpospholipid particles with included doxorubicine.
3 dwg, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
PHOSPHOLIPID COMPOSITION OF DOXORUBICIN FOR TREATING PATIENTS WITH BREAST CANCER | 2019 |
|
RU2714137C1 |
PHARMACEUTIC COMPOSITION INCLUDING ARBIDOL IN COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | 2009 |
|
RU2411942C2 |
BASED ON BOTANICAL PHOSPHOLIPIDS NANOSYSTEM FOR ACTUATION OF BIOLOGICALLY ACTIVE COMPOUNDS, AND METHOD OF ITS MANUFACTURE (VERSIONS) | 2009 |
|
RU2391966C1 |
LIPID DERIVATIVE OF SARCOLYSIN IN THE COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | 2017 |
|
RU2662086C1 |
PHARMACEUTICAL COMPOSITION OF INDOMETACIN INCLUDED IN PHOSPHOLIPID NANOPARTICLES FOR TREATING RHEUMATIC AND INFLAMMATORY DISEASES | 2009 |
|
RU2417079C1 |
COMPOSITION OF DIHYDROQUERCETINE ENCLOSED IN PHOSPHOLIPID NANOPARTICLES | 2013 |
|
RU2536208C1 |
METHOD FOR PRODUCING COMPOSITION FOR PHOTODYNAMIC THERAPY IN FORM OF PHOSPHOLIPID NANOPARTICLES BASED ON GLUCAMINE CHLORINE E6 SALT, MALTOSE AND PHOSPHATIDYLCHOLINE | 2014 |
|
RU2576025C1 |
COMPOSITION FOR DRUG SUBSTANCE INTEGRATION INTO LIPID MATRIX, DRUG COMPOSITION WITH PHOSPHOLIPID FATTY ACID SYSTEM AND METHOD FOR PREPARING THEM | 2011 |
|
RU2463056C1 |
PHOSPHOLIPID NANOPARTICLE INDOMETACIN APPLICABLE IN OPHTHALMOLOGY | 2011 |
|
RU2456979C1 |
METHOD FOR PREPARING PHOSPHOLIPID NANOPARTICLE ENCLOSED CHLORINE E6 COMPOSITION FOR PHOTODYNAMIC THERAPY | 2013 |
|
RU2535054C1 |
Authors
Dates
2011-02-20—Published
2009-08-25—Filed